Non-HLA genetics and predicting outcome in HSCT (original) (raw)

Importance of Non-HLA Gene Polymorphisms in Hematopoietic Stem Cell Transplantation

New Advances in Stem Cell Transplantation, 2012

T-cell depletion to prevent GVHD after unrelated-donor marrow transplantation

Lancet, 2005

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

Michael Maris

British Journal of Haematology, 2005

View PDFchevron_right

Association Between Human Leukocyte Antigens and Graft-Versus-Host Disease Occurrence in Allogeneic Hematopoietic Stem Cell Transplantation – A 10-Year Experience on Iranian Patients

MOHSEN HAMIDPOUR

Archives of Iranian Medicine

View PDFchevron_right

LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1

Tina Dalianis

Transplantation, 1998

View PDFchevron_right

Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft

CAROLINA ESTEFANIA FONSECA HERRERA

Bone Marrow Transplantation, 1999

View PDFchevron_right

The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors

O. Ringdén

Bone Marrow Transplantation, 2002

View PDFchevron_right

Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia

Tokiko Nagamura-Inoue

Bone Marrow Transplantation, 2013

View PDFchevron_right

The Influence of Human Leukocyte Antigens in Graft Versus Host Disease and Survival After Hematopoiet ic Stem Cell Transplantation in Pediatric Patients with Leukemia

Kursat Ozdilli

Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2021

View PDFchevron_right

Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants

Henrique Bittencourt

Experimental Hematology, 2001

View PDFchevron_right

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders

Marcelo A Fernandez-vina

Bone marrow transplantation, 2018

View PDFchevron_right

Background to hematopoietic cell transplantation, including post transplant immune recovery

A. Toubert

Bone Marrow Transplantation, 2009

View PDFchevron_right

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Michael Maris

Blood, 2003

View PDFchevron_right

Arturo Molina, Koen van Besien

Biology of Blood and Marrow Transplantation, 2008

View PDFchevron_right

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning …

Richard Maziarz

Biology of Blood and …, 2008

View PDFchevron_right

16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Eric Spierings, Anne Cesbron

International Journal of Immunogenetics, 2012

View PDFchevron_right

Protective Effect of HLA-E∗0101∕∗0103 Genotype in Survival of Patients After Allogeneic Hematopoietic Stem Cell Transplant

Meysam Sarshar

Experimental and Clinical Transplantation, 2020

View PDFchevron_right

Clinical Significance of HLA-E*0103 Homozygosity on Survival After Allogeneic Hematopoietic Stem-Cell Transplantation

Johannes Pröll

Transplantation, 2009

View PDFchevron_right

6th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Eric Spierings

View PDFchevron_right

A randomized multicenter comparison of CD34+-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies

Eefke Petersen

Experimental Hematology, 2003

View PDFchevron_right

COMPARISON OF GRAFT-VS-HOST-DISEASE AND SURVIVAL AFTER HLA IDENTICAL SIBLING BONE MARROW TRANSPLANTATION IN DIFFERENT ETHNIC POPULATIONS Running Head: Graft-vs-host disease in ethnic populations For Submission to BLOOD, Clinical Observations

Matthew Carabasi

2004

View PDFchevron_right

Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies

Stephen Schey

Biology of Blood and Marrow Transplantation, 2014

View PDFchevron_right

Long-term allogeneic hematopoietic cells transplantation survivors proinflammatory cytokine profile compared to their respective donors and immunophenotype differences depending on GvHD history and infection status

Mikołaj Młyński

Acta Haematologica Polonica

View PDFchevron_right

HLA-Haploidentical Stem Cell Transplantation for Hematologic Malignancies

Rita Carsetti

Biology of Blood and Marrow Transplantation, 2010

View PDFchevron_right

Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications

N. Mordini

British Journal of Haematology, 1997

View PDFchevron_right

High Risk HLA Allele for Severe Acute Graft-Versus-Host-Disease and Mortality in Unrelated Donor Hematopoietic Stem Cell Transplantation

Hiroh Saji

Biology of Blood and Marrow Transplantation, 2016

View PDFchevron_right

Non-HLA genetics and predicting outcome in HSCT (original) (raw)

Related papers